TECVAYLI 153MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: JOHNSON & JOHNSON (ONCOLOGY DIV)

MRP: ₹332074.11

JOHNSON & JOHNSON (ONCOLOGY DIV): Tecvayli 153MG Injection, 1 vial, salt teclistamab 153mg. Its MRP stays at Rs 332,074.11 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 253,008.85. Group: BCMA x CD3 bispecific antibody (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: step-up doses need hospital monitoring; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.